Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
Condition(s):Hypercholesterolemia; HypertriglyceridemiaLast Updated:February 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Hypercholesterolemia; HypertriglyceridemiaLast Updated:February 15, 2022Completed
Condition(s):Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Tay Sachs Disease; Sandhoffs Disease; Wolman Disease; I-Cell Disease; Sanfilippo Syndrome; GM1 GangliosidosisLast Updated:July 11, 2019Completed
Condition(s):Familial HypercholesterolemiaLast Updated:October 4, 2023Recruiting
Condition(s):Dyslipidemias; Hypercholesterolemia; Familial Hypercholesterolemia; ASCVD; High CholesterolLast Updated:March 12, 2024Recruiting
Condition(s):Dyslipidemias; High Cholesterol; Hypercholesterolemia; Familial Hypercholesterolemia; Atherosclerotic Cardiovascular DiseaseLast Updated:September 18, 2023Active, not recruiting
Condition(s):HypercholesteremiaLast Updated:June 25, 2020Completed
Condition(s):Non-familial Hypercholesterolemia; Mixed HyperlipidemiaLast Updated:January 31, 2024Completed
Condition(s):Heterozygous Familial HypercholesterolemiaLast Updated:December 11, 2023Completed
Condition(s):Hypercholesterolemia; Hypercholesterolemia, Familial; Hypercholesteremia in Children; Hyperlipidemia in ChildrenLast Updated:November 7, 2023Completed
Condition(s):Homozygous Familial Hypercholesterolemia; HoFHLast Updated:May 23, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.